Bams Abila

596 total citations · 1 hit paper
17 papers, 384 citations indexed

About

Bams Abila is a scholar working on Neurology, Molecular Biology and Dermatology. According to data from OpenAlex, Bams Abila has authored 17 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 5 papers in Molecular Biology and 4 papers in Dermatology. Recurrent topics in Bams Abila's work include Dermatology and Skin Diseases (4 papers), Drug-Induced Adverse Reactions (3 papers) and Neurological disorders and treatments (3 papers). Bams Abila is often cited by papers focused on Dermatology and Skin Diseases (4 papers), Drug-Induced Adverse Reactions (3 papers) and Neurological disorders and treatments (3 papers). Bams Abila collaborates with scholars based in United Kingdom, Nigeria and United States. Bams Abila's co-authors include Yasser Mostafa Kamel, Yi–Ju Chen, A. Richens, R. W. Marshall, John A. Davies, Patrick Sunday Igbigbi, Monica Simeoni, J. Frank Wilson, Lori Enney and Nicola Scott and has published in prestigious journals such as Neurology, Stroke and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Bams Abila

17 papers receiving 362 citations

Hit Papers

CAR-T: What Is Next? 2023 2026 2024 2025 2023 40 80 120

Peers

Bams Abila
Tarik Touil Morocco
Yeong Jin Kim South Korea
Kati Pummi Finland
Doina Manu Romania
Mi‐Hyeon You South Korea
Bams Abila
Citations per year, relative to Bams Abila Bams Abila (= 1×) peers Guan‐Ting Liu

Countries citing papers authored by Bams Abila

Since Specialization
Citations

This map shows the geographic impact of Bams Abila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bams Abila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bams Abila more than expected).

Fields of papers citing papers by Bams Abila

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bams Abila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bams Abila. The network helps show where Bams Abila may publish in the future.

Co-authorship network of co-authors of Bams Abila

This figure shows the co-authorship network connecting the top 25 collaborators of Bams Abila. A scholar is included among the top collaborators of Bams Abila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bams Abila. Bams Abila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Yi–Ju, Bams Abila, & Yasser Mostafa Kamel. (2023). CAR-T: What Is Next?. Cancers. 15(3). 663–663. 142 indexed citations breakdown →
2.
Abila, Bams, et al.. (2018). Current Trends in the Clinical Development of Antibody-Drug Conjugates in Oncology. Pharmaceutical Medicine. 32(4). 259–273. 8 indexed citations
3.
Al‐Sarraj, Safa, Andrew King, Andrea M. Corse, et al.. (2014). Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study. Acta Neuropathologica Communications. 2(1). 165–165. 42 indexed citations
5.
Cramer, Steven C., Bams Abila, Nicola Scott, Monica Simeoni, & Lori Enney. (2013). Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Repeat Doses of GSK249320 in Patients With Stroke. Stroke. 44(5). 1337–1342. 24 indexed citations
6.
Abila, Bams, Edwin J. Cunningham, & Monica Simeoni. (2012). First-Time-in-Human Study With GSK249320, a Myelin-Associated Glycoprotein Inhibitor, in Healthy Volunteers. Clinical Pharmacology & Therapeutics. 93(2). 163–169. 10 indexed citations
7.
Abila, Bams, et al.. (1994). Effects of two antihistamines on chloroquine and histamine induced weal and flare in healthy African volunteers.. PubMed. 23(2). 139–42. 26 indexed citations
8.
Abila, Bams, A. Richens, & John A. Davies. (1993). Anticonvulsant effects of extracts of the West African black pepper, Piper guineense. Journal of Ethnopharmacology. 39(2). 113–117. 31 indexed citations
9.
Abila, Bams. (1993). Anticonvulsant effects of the West African black pepper. Medical Entomology and Zoology. 39. 113–117. 5 indexed citations
10.
Abila, Bams. (1991). Essential tremor: a review.. PubMed. 10(1). 426–32. 8 indexed citations
11.
Igbigbi, Patrick Sunday, et al.. (1991). Halofantrine-induced pruritus amongst subjects who itch to chloroquine.. PubMed. 94(3). 184–8. 10 indexed citations
12.
Ezeamuzie, Charles I., et al.. (1990). Urine methylhistamine concentrations before and after chloroquine in healthy black subjects.. PubMed. 93(6). 423–5. 10 indexed citations
13.
Abila, Bams, et al.. (1989). Effects of clemastine, ketotifen and prednisolone on chloroquine-induced pruritus.. PubMed. 92(5). 356–9. 6 indexed citations
14.
Abila, Bams, J. Frank Wilson, R. W. Marshall, & A. Richens. (1986). Exercise-induced hand tremor: a possible test for beta 2-adrenoceptor selectivity in man?. PubMed. 22(1). 104–7. 11 indexed citations
16.
Abila, Bams, John H. Lazarus, J.C. Kingswood, et al.. (1985). Tremor: an alternative approach for investigating adrenergic mechanisms in thyrotoxicosis?. Clinical Science. 69(4). 459–463. 8 indexed citations
17.
Abila, Bams, J. Frank Wilson, R. W. Marshall, & A. Richens. (1985). Differential effects of alpha-adrenoceptor blockade on essential, physiological and isoprenaline-induced tremor: evidence for a central origin of essential tremor.. Journal of Neurology Neurosurgery & Psychiatry. 48(10). 1031–1036. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026